| Robert Fred Holder, MD | |
|
2106 Hale Ave, Harlingen, TX 78550-8408 | |
| (956) 423-9111 | |
| (956) 423-9273 |
| Full Name | Robert Fred Holder |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 29 Years |
| Location | 2106 Hale Ave, Harlingen, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588648075 | NPI | - | NPPES |
| 0038GV | Other | TX | BLUE CROSS/BLUE SHIELD |
| 129756100 | Other | TX | VALLEY HEALTH PLANS |
| 143421901 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | K9802 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harlingen Medical Center | Harlingen, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Padmini Bhadriraju Md P.a. | 7214118173 | 16 |
News Archive
The University of Massachusetts Medical School has licensed "anti-gal" technology developed by Professor of Surgery and Medicine Uri Galili, PhD, to newly formed biopharmaceutical company Agalimmune Ltd. for the purpose of developing innovative immunotherapies for the treatment of solid tumor cancers. Agalimmune is supported by an investment group comprising Loxbridge Research LLP and Animatrix Capital LLP and is based in London and California.
This supplement (.pdf) by Mediaplanet, distributed in the September 15 issue of USA Today in select cities nationwide, examines the latest programs dedicated to eradicating neglected tropical diseases (NTDs) worldwide.
Past exposure to seasonal coronaviruses (CoVs), which cause the common cold, does not result in the production of antibodies that protect against the novel coronavirus SARS-CoV-2, according to a study led by Scott Hensley, PhD, an associate professor of Microbiology at the Perelman School of Medicine at the University of Pennsylvania.
A retrospective analysis of a large U.S. managed care database showed that patients who took Pfizer's cholesterol-lowering medicine Lipitor (atorvastatin calcium) Tablets had a significant 14 percent reduction in the risk of cardiovascular events, including heart attacks and strokes, compared with patients who took simvastatin.
› Verified 8 days ago
| Entity Name | Padmini Bhadriraju Md P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619278876 PECOS PAC ID: 7214118173 Enrollment ID: O20110224000875 |
News Archive
The University of Massachusetts Medical School has licensed "anti-gal" technology developed by Professor of Surgery and Medicine Uri Galili, PhD, to newly formed biopharmaceutical company Agalimmune Ltd. for the purpose of developing innovative immunotherapies for the treatment of solid tumor cancers. Agalimmune is supported by an investment group comprising Loxbridge Research LLP and Animatrix Capital LLP and is based in London and California.
This supplement (.pdf) by Mediaplanet, distributed in the September 15 issue of USA Today in select cities nationwide, examines the latest programs dedicated to eradicating neglected tropical diseases (NTDs) worldwide.
Past exposure to seasonal coronaviruses (CoVs), which cause the common cold, does not result in the production of antibodies that protect against the novel coronavirus SARS-CoV-2, according to a study led by Scott Hensley, PhD, an associate professor of Microbiology at the Perelman School of Medicine at the University of Pennsylvania.
A retrospective analysis of a large U.S. managed care database showed that patients who took Pfizer's cholesterol-lowering medicine Lipitor (atorvastatin calcium) Tablets had a significant 14 percent reduction in the risk of cardiovascular events, including heart attacks and strokes, compared with patients who took simvastatin.
› Verified 8 days ago
| Entity Name | Hni Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366735169 PECOS PAC ID: 6406028810 Enrollment ID: O20111031000750 |
News Archive
The University of Massachusetts Medical School has licensed "anti-gal" technology developed by Professor of Surgery and Medicine Uri Galili, PhD, to newly formed biopharmaceutical company Agalimmune Ltd. for the purpose of developing innovative immunotherapies for the treatment of solid tumor cancers. Agalimmune is supported by an investment group comprising Loxbridge Research LLP and Animatrix Capital LLP and is based in London and California.
This supplement (.pdf) by Mediaplanet, distributed in the September 15 issue of USA Today in select cities nationwide, examines the latest programs dedicated to eradicating neglected tropical diseases (NTDs) worldwide.
Past exposure to seasonal coronaviruses (CoVs), which cause the common cold, does not result in the production of antibodies that protect against the novel coronavirus SARS-CoV-2, according to a study led by Scott Hensley, PhD, an associate professor of Microbiology at the Perelman School of Medicine at the University of Pennsylvania.
A retrospective analysis of a large U.S. managed care database showed that patients who took Pfizer's cholesterol-lowering medicine Lipitor (atorvastatin calcium) Tablets had a significant 14 percent reduction in the risk of cardiovascular events, including heart attacks and strokes, compared with patients who took simvastatin.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Fred Holder, MD 2106 Hale Ave, Harlingen, TX 78550-8408 Ph: (956) 423-9111 | Robert Fred Holder, MD 2106 Hale Ave, Harlingen, TX 78550-8408 Ph: (956) 423-9111 |
News Archive
The University of Massachusetts Medical School has licensed "anti-gal" technology developed by Professor of Surgery and Medicine Uri Galili, PhD, to newly formed biopharmaceutical company Agalimmune Ltd. for the purpose of developing innovative immunotherapies for the treatment of solid tumor cancers. Agalimmune is supported by an investment group comprising Loxbridge Research LLP and Animatrix Capital LLP and is based in London and California.
This supplement (.pdf) by Mediaplanet, distributed in the September 15 issue of USA Today in select cities nationwide, examines the latest programs dedicated to eradicating neglected tropical diseases (NTDs) worldwide.
Past exposure to seasonal coronaviruses (CoVs), which cause the common cold, does not result in the production of antibodies that protect against the novel coronavirus SARS-CoV-2, according to a study led by Scott Hensley, PhD, an associate professor of Microbiology at the Perelman School of Medicine at the University of Pennsylvania.
A retrospective analysis of a large U.S. managed care database showed that patients who took Pfizer's cholesterol-lowering medicine Lipitor (atorvastatin calcium) Tablets had a significant 14 percent reduction in the risk of cardiovascular events, including heart attacks and strokes, compared with patients who took simvastatin.
› Verified 8 days ago
Jesus Rodriguez, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2222 Benwood St, Harlingen, TX 78550 Phone: 956-389-2448 | |
Bright Ohene Odei, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 707 W Sesame Dr, Harlingen, TX 78550 Phone: 956-423-8042 Fax: 469-893-7810 | |
Erica Ruiz Espinoza, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 707 W Sesame Dr, Harlingen, TX 78550 Phone: 956-423-8042 Fax: 956-423-2907 | |
Mr. Prasad V Movva, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 922 E Tyler Ave, Harlingen, TX 78550 Phone: 956-440-7000 Fax: 956-440-7042 | |
Dr. Jason E Peters, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2106 Hale Avenue, Harlingen, TX 78550 Phone: 956-423-9111 Fax: 956-423-9273 | |
Dr. John Barry Ranelle, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1214 E Bowie Ave, Harlingen, TX 78550 Phone: 956-536-7794 Fax: 956-686-2708 | |
Edward G. Oorjitham, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1205 N Ed Carey Dr, Suite 2c, Harlingen, TX 78550 Phone: 956-440-8020 Fax: 956-440-8131 |